Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.
Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation. Am J Respir Cell Mol Biol. 2016 09; 55(3):419-28.
View in:
PubMed
subject areas
Animals
Animals
Animals, Newborn
Animals, Newborn
Auranofin
Auranofin
Aurothioglucose
Aurothioglucose
Body Weight
Body Weight
Cell Line
Cell Line
Gene Expression Regulation
Gene Expression Regulation
Heme Oxygenase-1
Heme Oxygenase-1
Hyperoxia
Hyperoxia
Lung Injury
Lung Injury
Mice
Mice
Mice, Inbred C3H
Mice, Inbred C3H
Morphogenesis
Morphogenesis
NAD(P)H Dehydrogenase (Quinone)
NAD(P)H Dehydrogenase (Quinone)
NF-E2-Related Factor 2
NF-E2-Related Factor 2
Pulmonary Alveoli
Pulmonary Alveoli
RNA, Messenger
RNA, Messenger
Thioredoxin-Disulfide Reductase
Thioredoxin-Disulfide Reductase
authors with profiles
Trent E Tipple